guy young: fitusiran for hemophilia a and b with inhibitors
Published 2 years ago • 774 plays • Length 7:56Download video MP4
Download video MP3
Similar videos
-
3:04
fitusiran significantly reduces bleeding events in patients with hemophilia a or b, with inhibitors
-
1:48
the promise of fitusiran for the treatment of patients with hemophilia a and b
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
3:29
fitusiran prophylaxis shows encouraging results in hemophilia patients
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
3:31
fitusiran and hemophilia: early data very promising
-
3:00
eptacog beta efficacy in children and adolescents with hemophilia a or b with inhibitors
-
22:18
dr. guy young discusses the latest advances in gene therapy in hemophilia
-
1:23
the safety and efficacy of eptacog beta in patients with hemophilia
-
4:01
amy shapiro: sig-001 cell therapy for hemophilia a
-
58:00
overview of world federation of hemophilia treatment guidelines, 3rd edition
-
9:36
hemophilia (year of the zebra)
-
58:32
novel therapies in hemophilia - ashok b. raj, m.d.
-
46:56
an exploration of why men with severe haemophilia might not want gene therapy: the exigency study
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
3:31
hemophilia a and b, new phase ii data confirming fitusiran and rna interference technology
-
1:02:24
advancements in treatment for hemophilia: what you need to know
-
1:00:55
science update state of the science on inhibitors
-
58:44
cdc webinar: new opportunities and challenges in hemophilia care